K Dolasia, MK Bisht, G Pradhan, A Udgata… - International Reviews …, 2018 - Taylor & Francis
Innate immune system provides the first line of defense against pathogenic organisms. It has a varied and large collection of molecules known as pattern recognition receptors (PRRs) …
G Zhang, B Chan, N Samarina… - Proceedings of the …, 2016 - National Acad Sciences
The latency-associated nuclear antigen (LANA) of Kaposi sarcoma herpesvirus (KSHV) is mainly localized and functions in the nucleus of latently infected cells, playing a pivotal role …
Worldwide, one fifth of cancers in the population are associated with viral infections. Among them, gammaherpesvirus, specifically HHV4 (EBV) and HHV8 (KSHV), are two oncogenic …
Y Izumiya, A Algalil, JM Espera, H Miura… - Journal of …, 2024 - Am Soc Microbiol
The Kaposi's sarcoma-associated herpesvirus (KSHV) genome consists of an approximately 140-kb unique coding region flanked by 30–40 copies of a 0.8-kb terminal repeat (TR) …
G Broussard, B Damania - Frontiers in immunology, 2020 - frontiersin.org
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is associated with KS, primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD). To ensure its own …
B Damania, DP Dittmer - Journal of medical virology, 2023 - Wiley Online Library
This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that manifests under diverse and divergent circumstances. We begin with a historical …
P Dabral, J Babu, A Zareie, SC Verma - Journal of virology, 2020 - Am Soc Microbiol
During the latent phase, Kaposi's sarcoma-associated herpes virus (KSHV) maintains itself inside the host by escaping the host immune surveillance mechanism through restricted …
Herpesviruses hijack the MHC class I (MHC I) and class II (MHC II) antigen-presentation pathways to manipulate immune recognition by T cells. First, we illustrate herpes simplex …
K Brulois, Z Toth, LY Wong, P Feng, SJ Gao… - Journal of …, 2014 - Am Soc Microbiol
The downregulation of immune synapse components such as major histocompatibility complex class I (MHC-I) and ICAM-1 is a common viral immune evasion strategy that …